Jim Stallard, MA

Senior Writer/Editor

Recent Blog Posts

Pictured: Susan Prockop & Lucas T.
In the Clinic
Thursday, March 6, 2014

Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.

Pictured: Sergio Giralt
Honor
Wednesday, February 26, 2014

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

Pictured: Abraham Wu
Ask the Expert
Monday, February 24, 2014

CyberKnife is a brand name for one of several available devices that deliver intense doses of radiation with very high accuracy.

Pictured: Stephen Solomon
In the Clinic
Monday, January 27, 2014

Irreversible electroporation – a new, minimally invasive treatment that uses electric current to poke tiny holes in cell membranes – is showing promise against hard-to-treat tumors.

In the Clinic
Wednesday, January 22, 2014

Obesity in patients with early-stage tongue cancer has been linked to a five-fold increase in the risk of death.

Pictured: Alice Ho
In the Clinic
Monday, January 20, 2014

A new approach for treating breast cancer spreads radiation doses over a larger number of beams, providing more thorough coverage.

Pictured: Nai-Kong Cheung & Jeremy D
In the Lab
Thursday, January 9, 2014

Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.

Pictured: Natalie Moryl (Khojainova), MD
Ask the Expert
Wednesday, December 18, 2013

Memorial Sloan Kettering physician Natalie Moryl discusses pain medications in cancer treatment and why patients should not avoid them due to fears of addiction.

Pictured: Ross Levine
In the Clinic
Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Ellen Yorke and Karyn Goodman
In the Clinic
Wednesday, November 20, 2013

Memorial Sloan Kettering is exploring a precise form of high-dose radiation therapy for pancreatic cancer that could shorten treatment time and potentially be more effective.

Pictured: Sarat Chandarlapaty
In the Lab
Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Anas Younes, Chief, Lymphoma Service
Profile
Wednesday, October 30, 2013

Medical oncologist Anas Younes leads an ambitious effort to find disease biomarkers that could predict which lymphoma patients will benefit from new targeted therapies.

Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Pictured: Mark Robson
Q&A
Monday, October 21, 2013

As genome sequencing of tumors becomes more routine, it increases the odds that additional disease-related mutations may be discovered by accident, a development that raises profound issues.

Pictured: Sergio Giralt & Robin Roberts
Event
Thursday, October 17, 2013

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.